// App-Quantinova.ai

: Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme

Researchers

Presenter

  • Darush Attar

Principal Investigators

  • Toby Capstick

  • Deborah Leese

  • Sofie Arnetorp

  • Eleni Rapsomaniki

  • Keith Peres Da Costa

  • Yang Xu

  • Jennifer K Quint

Medical Centers

  • NHS North Central London CCG (Barnet Borough), London, United Kingdom

  • Astra Zeneca, Cambridge, United Kingdom

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • NHS Sheffield Clinical Commissioning Group, Sheffield, United Kingdom

  • AstraZeneca, Gothenburg, Sweden

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Locations

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved